FORTRESS BIOTECH INC (FBIO) Stock Income Statement
NASDAQ:FBIO - Nasdaq - US34960Q3074 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 57.67M | 84.51M | 75.74M | 68.79M | 45.60M | |||
| Minority Interest Expense | 74.86M | 93.52M | 127.34M | 100.12M | 56.46M | |||
| Cost Of Goods | 20.88M | 26.66M | 30.78M | 32.08M | 14.59M | |||
| Gross Profit | 36.80M | 57.85M | 44.97M | 36.71M | 31.01M | |||
| Operating Expenses | 148.04M | 197.09M | 248.53M | 215.71M | 125.28M | |||
| Research and Development | 56.88M | 106.07M | 134.88M | 128.87M | 64.11M | |||
| Selling, General, and Administrative Expenses | 87.73M | 91.02M | 113.66M | 86.84M | 61.17M | |||
| Operating Income | -111.24M | -139.24M | -203.56M | -179.00M | -94.27M | |||
| Interest Income/Expense | -11.48M | -12.31M | -11.20M | 24.19M | -8.58M | |||
| Other Income/Expense | 1.32M | 4.42M | 1.30M | N/A | N/A | |||
| Non Recurring Items | 861.00K | -6.50M | 0.00 | -9.54M | 0.00 | |||
| Income Before Taxes | -120.54M | -153.63M | -213.46M | -164.35M | -102.85M | |||
| Income Tax | 312.00K | 521.00K | 450.00K | 470.00K | 140.00K | |||
| Net Income | -55.89M | -68.67M | -86.58M | -64.70M | -46.53M | |||
| EBITDA | -106.78M | -133.25M | -196.17M | -173.90M | -90.57M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.69 | -8.47 | -14.61 | -11.88 | -9.69 | |||
| Non GAAP EPS | -3.27 | -8.97 | -14.51 | -6.24 | -0.63 | |||
| Statistics | ||||||||
| Gross Profit Margin | 63.80% | 68.45% | 59.37% | 53.37% | 68.00% | |||
| Profit Margin | -96.91% | -81.25% | -114.31% | -94.05% | -102.04% | |||
| Operating Profit Margin | -192.87% | -164.76% | -268.76% | -260.21% | -206.73% | |||
All data in USD